The goals of antiarrhythmic drug therapy are to control heart rate, abolish tachyarrhythmias, suppress ectopic beats, and to restore and maintain normal sinus rhythm. The selection of appropriate agents is a match between the common antiarrhythmic drugs, the condition and age of the patient, the urgency of treatment, the potential long-term side effects, and especially the drug's proven efficacy on the arrhythmia in question [1]. This chapter will discuss the pharmacokinetics and pharmacodynamics of the commonly utilized and marketed antiarrhythmic drugs. © 2009 Springer Berlin Heidelberg.
CITATION STYLE
Wayne Kreeger, R., Ali Raza, J., & Movahed, A. (2009). Anti-arrhythmic drugs: Pharmacokinetics and pharmacodynamics. In Integrating Cardiology for Nuclear Medicine Physicians: A Guide to Nuclear Medicine Physicians (pp. 453–461). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-78674-0_38
Mendeley helps you to discover research relevant for your work.